Anti-obesity drug Mounjaro is set to rack up global sales worth nearly £22bn a year by the end of the decade. But Donald Trump's 'America First' trade policies mean Britons could soon be paying more for the 'King Kong' of weight-loss jabs ➡️ Read More: https://trib.al/jhEp2QG